| abstract |
This application relates to a series of substituted pyrazolopyridin-6-amines having the general formula (I), including their stereoisomers and / or their pharmaceutically acceptable salts. In which R, R 1 , R 2 , R a , R aa , R b and n are as defined herein. The invention further relates to pharmaceutical compositions comprising a compound of formula (I). The compounds of the present application are useful as CETP inhibitors for increasing HDL cholesterol and decreasing LDL cholesterol in patients. |